WOOF

Petco Health & Wellness Company, Inc. - 10-Q Summary

Business Context and Reporting Period

This filing is a Quarterly Report on Form 10-Q for Petco Health & Wellness Company, Inc. (Petco) for the thirteen and thirty-nine weeks ended November 2, 2024. Petco operates as a pet health and wellness company with an omnichannel ecosystem comprising over 1,500 pet care centers in the U.S., Mexico, and Puerto Rico, alongside digital channels and in-store veterinary hospitals.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 1.2% year-over-year for the quarter, driven by a 5.0% increase in Services and Other and a 2.7% increase in Consumables. This was partially offset by a 2.8% decline in Supplies and Companion Animals due to softening discretionary spending.
• Profitability Improvement: Operating income improved significantly to $4.0 million from an operating loss of $1.23 billion in the prior year quarter. The prior year loss was primarily driven by a one-time goodwill impairment charge of $1.22 billion, which did not recur in the current period.
• Comparable Sales: Comparable sales increased 1.8% for the quarter and 0.3% for the year-to-date period.
• Expense Management: SG&A expenses increased 2.2% quarter-over-quarter due to higher payroll and occupancy costs, though stock compensation and advertising expenses decreased.

Outlook, Risks, and Commentary

• Management Commentary: Management highlights momentum in consumables and services, noting the maturity of the veterinary hospital footprint. However, they cite macroeconomic pressures, including inflation and interest rates, as drivers for reduced spending on discretionary items like supplies.
• Liquidity Position: The company maintains strong liquidity with $644.3 million available, consisting of cash on hand and $527.6 million of availability under its amended Asset-Based Lending (ABL) Revolving Credit Facility. Management believes current resources are sufficient for operations and capital investments for the next 12 months.
• Risks: Key risks include increased competition from mass retailers and e-commerce providers, macroeconomic pressures affecting consumer spending, supply chain constraints, and the ability to effectively manage costs and execute transformation initiatives.
• Unusual Items: The prior year period included a significant non-cash goodwill impairment of $1.22 billion. The current period includes $8.5 million in other non-operating income related to the remeasurement of an equity investment.

Investor Verification Checklist

• Goodwill Impairment History: Verify the impact of the $1.22 billion impairment recorded in Q3 2023 on current valuation metrics and future impairment risks given share price volatility.
• Discretionary Spend Trends: Monitor the continued decline in "Supplies and Companion Animals" sales to assess the severity of macroeconomic headwinds on core retail categories.
• Debt Covenants: Review compliance with covenants under the First Lien Term Loan and ABL Revolving Credit Facility, particularly regarding borrowing base calculations.
• Capital Expenditures: Assess the reduction in capital spend (down to $91 million YTD from $176 million prior year) and its impact on future store/hospital expansion plans.
• Adjusted EBITDA Reconciliation: Scrutinize the adjustments made to reach Adjusted EBITDA, specifically the treatment of the Mexico joint venture and "other costs."